Tower Research Capital LLC TRC boosted its stake in Prestige Consumer Healthcare Inc (NYSE:PBH) by 100.6% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,657 shares of the company’s stock after acquiring an additional 831 shares during the period. Tower Research Capital LLC TRC’s holdings in Prestige Consumer Healthcare were worth $57,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds also recently made changes to their positions in the stock. Tibra Equities Europe Ltd purchased a new stake in Prestige Consumer Healthcare in the third quarter valued at $465,000. Russell Investments Group Ltd. increased its stake in Prestige Consumer Healthcare by 15.7% in the third quarter. Russell Investments Group Ltd. now owns 396,109 shares of the company’s stock valued at $13,676,000 after purchasing an additional 53,620 shares during the period. BB&T Corp increased its stake in Prestige Consumer Healthcare by 1.8% in the third quarter. BB&T Corp now owns 28,512 shares of the company’s stock valued at $989,000 after purchasing an additional 511 shares during the period. Texas Yale Capital Corp. acquired a new position in Prestige Consumer Healthcare in the third quarter valued at $205,000. Finally, Oppenheimer Asset Management Inc. increased its stake in Prestige Consumer Healthcare by 113.6% in the third quarter. Oppenheimer Asset Management Inc. now owns 771 shares of the company’s stock valued at $27,000 after purchasing an additional 410 shares during the period.
In related news, insider Paton Brett 586,594 shares of the company’s stock in a transaction that occurred on Monday, November 11th. Insiders own 1.14% of the company’s stock.
NYSE PBH opened at $38.84 on Monday. The company has a debt-to-equity ratio of 1.60, a quick ratio of 1.22 and a current ratio of 2.08. The firm has a market cap of $1.96 billion, a PE ratio of 13.97, a P/E/G ratio of 2.13 and a beta of 0.91. Prestige Consumer Healthcare Inc has a one year low of $26.25 and a one year high of $39.46. The firm’s fifty day moving average is $37.41 and its two-hundred day moving average is $33.84.
Prestige Consumer Healthcare (NYSE:PBH) last posted its quarterly earnings data on Thursday, October 31st. The company reported $0.68 EPS for the quarter, beating analysts’ consensus estimates of $0.66 by $0.02. The company had revenue of $238.07 million for the quarter, compared to analyst estimates of $237.17 million. Prestige Consumer Healthcare had a negative net margin of 3.56% and a positive return on equity of 12.68%. Prestige Consumer Healthcare’s quarterly revenue was down .5% on a year-over-year basis. During the same period in the previous year, the business posted $0.65 earnings per share. Research analysts predict that Prestige Consumer Healthcare Inc will post 2.82 earnings per share for the current year.
Prestige Consumer Healthcare Profile
Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare and household cleaning products in North America, Australia, and internationally. It operates in three segments: North American OTC Healthcare, International OTC Healthcare, and Household Cleaning.
Further Reading: How to Invest in Stocks with Increasing Dividends
Receive News & Ratings for Prestige Consumer Healthcare Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com’s FREE daily email newsletter.
